cvs caremark glp-1 coverage news is adding Zepbound, Eli Lilly's obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk's Wegovy. MORE CVS halts Zepbound coverage, cites

In this video, I share simple, effective tips to...

At the same time, payer policies often require discontinuation of GLP-1 therapy when a patients BMI drops below a set threshold, inadvertently triggering a frustrating cycle of weight loss and regainthe so-called yo-yo effect. This not only impacts ongoing adherence and persistence but also undermines the long-term cost-effectiveness of these therapies for healthcare systems

A 2026 review of six studies found that people with diabetes or obesity taking GLP-1 medications were prone to developing a number of nutrient deficiencies, particularly in vitamin D, iron, and B v...

Learn why Flow Wellness follows this rule to keep you safe.

Mounjaro can potentially cause dyspnea in some patients, and it is essential to monitor patients with pre-existing respiratory conditions closely when starti...